✦ LIBER ✦

A trial of L-Deprenyl for the treatment of neuroleptic-induced parkinsonism

✍ Scribed by A. Rapoport; D. Stein; M. Schwartz; J. Levin; S. Stier; A. Elizur; J. M. Rabey

Publisher: Springer
Year: 1999
Tongue: English
Weight: 78 KB
Volume: 106
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020050210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of sustained deprenyl (selegiline

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

✍ Ira Shoulson; David Oakes; Stanley Fahn; Anthony Lang; J. William Langston; Pete 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

Parenteral ziprasidone: a new atypical n

Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?

✍ Matthias Oechsner; Alexei Korchounov 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10-20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen.

Increased life expectancy resulting from

Increased life expectancy resulting from addition of l-deprenyl to Madopar®treatment in Parkinson's disease: A longterm study

✍ W. Birkmayer; J. Knoll; P. Riederer; M. B. H. Youdim; Vera Hars; J. Marton 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 760 KB

Efficacy of nefazodone in the treatment

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial

✍ Dora Wynchank; Michael Berk 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

## Abstract Many atypical antipsychotics show antagonism at both serotonergic and dopaminergic neurones and show fewer extrapyramidal side effects (EPS). Nefazodone blocks postsynaptic 5HT~2A~ receptors and weakly inhibits serotonin reuptake. This study aimed to elucidate the role of nefazodone in

Acute parkinsonism induced by the combin

Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome

✍ Dr. Roger Kurlan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Neuroleptics are the most effective tic-suppressing drugs in treating Tourette's syndrome (TS).' When compared with the high neuroleptic dosages typically used to treat psychiatric disorders, the low dosages used in TS uncommonly cause druginduced parkinsonism.' A selective serotonin reuptake inhibi

Risperidone in the treatment of dopamine

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

✍ Erich Mohr; Tilak Mendis; Kathleen Hildebrand; Peter Paul De Deyn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Purpose: To evaluate the safety and efficacy of risperidone in patients with parkinson's disease (pd) who are experiencing significant dopamine-induced psychosis. ## Patients and methods: Seventeen patients (median age, 72 yrs) participated in this 12-week, open pilot study receiving 0.5 to 3